Nebivolol
- TRADE NAMES: Bystolic (Forest); Byvalson (Forest); Nebilet (Menarini)
- INDICATIONS: Hypertension
- CLASS: Adrenergic beta-receptor antagonist, Beta blocker
- HALF-LIFE: 8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Beta blockers, Cinacalcet, Clonidine, CYP2D6 inhibitors, Delavirdine, Digitalis glycosides, Duloxetine, Terbinafine, Tipranavir, Viloxazine
PREGNANCY CATEGORY: C
Byvalson is nebivolol and valsartan.
Byvalson: FETAL TOXICITY
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 02/16/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric